A detailed history of Cerity Partners LLC transactions in Cerus Corp stock. As of the latest transaction made, Cerity Partners LLC holds 32,631 shares of CERS stock, worth $58,409. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,631
Holding current value
$58,409
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.7 - $2.39 $55,472 - $77,988
32,631 New
32,631 $56,000
Q1 2024

May 14, 2024

BUY
$1.66 - $2.42 $42,721 - $62,281
25,736 New
25,736 $48,000
Q3 2021

Oct 25, 2021

SELL
$4.79 - $6.68 $119,750 - $167,000
-25,000 Closed
0 $0
Q1 2021

Aug 11, 2021

BUY
$5.68 - $7.87 $142,000 - $196,750
25,000 New
25,000 $150,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.